NFkB EMSA (Electrophoretic-Mobility Shift Assay) kit is used for monitoring NFkB (Nuclear factor of kappa light polypeptide gene) DNA binding
NF-κB-DICER-miRs Axis Regulates TNF-α Expression in Responses to Endotoxin Stress
Attenuation of the upregulation of NF‑κB and AP‑1 DNA‑binding activities induced by tunicamycin or hypoxia/reoxygenation in neonatal rat cardiomyocytes by SERCA2a overexpression
EMSA-related Products
Quantitatively Measure NF-kB Activation with TransAM Assays
Chemiluminescent EMSA kit, LightShift™
NFkB Responsive Luciferase Reporter HepG2 Stable Cell Line is derived from human liver cancer, and stably express firefly luciferase reporter gene
NFkB Luciferase Reporter HepG2 Stable Cell Line SL-0017 | Signosis
Analysis of DNA binding to NF-κB binding site. EMSA was carried out
for Measurement of Human NF-kB p65 in
NF-kB p65 ELISA Kit
EMSA Oligos, Mandel Scientific
Attenuation of the upregulation of NF‑κB and AP‑1 DNA‑binding activities induced by tunicamycin or hypoxia/reoxygenation in neonatal rat cardiomyocytes by SERCA2a overexpression
NFkB EMSA (Electrophoretic-Mobility Shift Assay) kit is used for monitoring NFkB (Nuclear factor of kappa light polypeptide gene) DNA binding
NFkB EMSA Kit
Transcriptional profiling of the LPS induced NF-κB response in macrophages, BMC Immunology
LightShift™ Chemiluminescent EMSA Kit
NFkB p65 peptide (contains Ser529/536 sites) for inhibition of NFkB p65 inhibitor peptide (contains Ser529/536 sites) used in assays to inhibit NF-kB
RelA/NFkB p65 [p Ser529, p Ser536] Inhibitor Peptide Set